In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...
A mechanotransduction-aware strategy for enhancing MSC potency via 3D culture and localized delivery
A research paper by scientists from Tongji University developed a groundbreaking mechanotransduction-aware therapeutic ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results